Behind The Ch. 15 Filing Of Immunology Co. VBI Vaccines
After accumulating more than half a billion dollars of deficits over its history, VBI Vaccines, a developer of COVID-19 and hepatitis B vaccines, was unable to avoid bankruptcy court as it...To view the full article, register now.
Already a subscriber? Click here to view full article